XWELL shares surge 13.77% intraday as strategic partnership with PieQ advances AI-powered biosecurity platform amid CDC milestone.

XWELL surged 13.77% in intraday trading following the announcement of a strategic partnership with AI firm PieQ to develop an AI-powered biosecurity forecasting platform. The collaboration, aimed at enhancing the CDC’s Traveler-based Genomic Surveillance program, leverages real-time aviation and passenger data to predict international traveler arrivals at city and flight levels, enabling proactive biosecurity resource allocation. The CDC’s TGS program recently surpassed one million voluntary participants, underscoring the program’s scalability and relevance. By embedding AI-driven forecasting into operations, XWELL aims to strengthen early detection of biothreats, particularly ahead of high-traffic events like the 2026 World Cup. The partnership highlights XWELL’s expansion into predictive intelligence for public health, aligning with growing demand for scalable biosecurity solutions amid global travel surges.